Lucid Diagnostics Inc.
NASDAQ:LUCD
0.7643 (USD) • At close December 24, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2018 Q4 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 1.172 | 0.976 | 1.001 | 1.04 | 0.783 | 0.159 | 0.446 | 0.112 | 0.076 | 0 | 0.189 | 0.3 | 0.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of Revenue
| 1.684 | 1.843 | 2.157 | 2.086 | 1.634 | 1.549 | 1.338 | 1.618 | 1.626 | 0.704 | 0.369 | 0.441 | 0.144 | 0 | 0.003 | 0 | 0 | 0 | 0 | 0 |
Gross Profit
| -0.512 | -0.867 | -1.156 | -1.046 | -0.851 | -1.39 | -0.892 | -1.506 | -1.55 | -0.704 | -0.18 | -0.141 | 0.056 | -0 | -0.003 | 0 | 0 | 0 | 0 | 0 |
Gross Profit Ratio
| -0.437 | -0.888 | -1.155 | -1.006 | -1.087 | -8.742 | -2 | -13.446 | -20.395 | 0 | -0.952 | -0.469 | 0.279 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Reseach & Development Expenses
| 1.666 | 1.372 | 1.501 | 1.918 | 1.615 | 1.827 | 2.282 | 2.442 | 2.704 | 3.44 | 2.881 | 3.482 | 2.19 | 1.873 | 1.752 | 1.826 | 1.216 | 0.866 | 1.534 | 0.645 |
General & Administrative Expenses
| 5.355 | 4.867 | 4.07 | 4.205 | 4.32 | 3.83 | 6.511 | 5.462 | 5.66 | 7.311 | 5.718 | 2.358 | 4.376 | 3.122 | 1.212 | 0.905 | 0.805 | 0.444 | 0.683 | 0.417 |
Selling & Marketing Expenses
| 4.056 | 4.21 | 4.194 | 4.408 | 3.837 | 4.032 | 4.127 | 5.013 | 3.93 | 3.873 | 3.318 | 5.26 | 0.918 | 1.021 | 0.689 | 0.633 | 0.335 | 0 | 0 | 0 |
SG&A
| 9.301 | 9.077 | 8.135 | 8.489 | 8.157 | 7.862 | 10.638 | 10.475 | 9.59 | 11.184 | 9.036 | 7.618 | 4.376 | 4.143 | 1.901 | 0.905 | 0.805 | 0.444 | 0.683 | 0.417 |
Other Expenses
| 0 | 0 | 372 | 0.54 | -3.021 | 505 | 0.505 | 0.505 | 0.505 | 0 | -0.173 | 0 | 833,775 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Expenses
| 10.967 | 10.325 | 9.636 | 10.407 | 10.277 | 10.194 | 13.425 | 13.422 | 12.799 | 14.624 | 11.917 | 11.1 | 6.566 | 6.016 | 3.653 | 2.731 | 2.022 | 1.31 | 2.217 | 1.062 |
Operating Income
| -11.694 | -11.192 | -10.792 | -11.453 | -11.128 | -11.584 | -14.317 | -14.928 | -14.349 | -14.624 | -12.097 | -11.24 | -6.51 | -6.016 | -3.653 | -2.731 | -2.022 | -1.31 | -2.217 | -1.062 |
Operating Income Ratio
| -9.978 | -11.467 | -10.781 | -11.013 | -14.212 | -72.855 | -32.101 | -133.286 | -188.803 | 0 | -64.005 | -37.468 | -32.549 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Other Income Expenses Net
| -0.677 | 0.187 | 0.18 | 0.623 | -3.08 | 0.203 | -1.93 | 0 | 0 | 0.004 | 0.001 | -0.065 | -0.447 | -0.147 | 0 | 0 | 0 | 0 | 0 | 0 |
Income Before Tax
| -12.371 | -11.005 | -10.612 | -10.83 | -14.208 | -11.381 | -16.247 | -14.928 | -14.349 | -14.624 | -12.27 | -11.306 | -6.957 | -6.163 | -3.653 | -2.731 | -2.022 | -1.31 | -2.217 | -1.062 |
Income Before Tax Ratio
| -10.555 | -11.276 | -10.601 | -10.413 | -18.146 | -71.579 | -36.428 | -133.286 | -188.803 | 0 | -64.921 | -37.685 | -34.783 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Income Tax Expense
| 0 | 0 | 7,496 | -1,960.351 | -2.872 | 0.223 | 1,963 | -0.173 | 0.566 | 0.004 | 0.173 | 0.065 | 0.447 | 0.147 | 0 | -2.731 | -2.022 | 0 | 0 | 0 |
Net Income
| -12.371 | -11.005 | -10.612 | -10.83 | -14.208 | -11.381 | -1,979.247 | -14.755 | -14.349 | -14.624 | -12.443 | -11.306 | -6.957 | -6.163 | -3.653 | -2.731 | -2.022 | -1.31 | -2.217 | -1.062 |
Net Income Ratio
| -10.555 | -11.276 | -10.601 | -10.413 | -18.146 | -71.579 | -4,437.774 | -131.741 | -188.803 | 0 | -65.836 | -37.685 | -34.783 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS
| -0.25 | -0.23 | -0.24 | -0.26 | -0.34 | -0.27 | -48.31 | -0.4 | -0.39 | -0.41 | -0.35 | -0.31 | -0.19 | -0.17 | -0.099 | -0.074 | -0.055 | -0.093 | -0.16 | -0.075 |
EPS Diluted
| -0.25 | -0.23 | -0.24 | -0.26 | -0.34 | -0.27 | -48.31 | -0.4 | -0.39 | -0.41 | -0.35 | -0.31 | -0.19 | -0.17 | -0.099 | -0.074 | -0.055 | -0.093 | -0.16 | -0.075 |
EBITDA
| -12.155 | -10.77 | -10.099 | -10.19 | -13.434 | -10.525 | -15.602 | -14.313 | -13.756 | -13.92 | -12.246 | -11.24 | -6.51 | -6.016 | -3.65 | -2.731 | -2.022 | 0 | 0 | 0.563 |
EBITDA Ratio
| -10.371 | -11.035 | -10.281 | -10.408 | -17.124 | -68.019 | -34.982 | -127.795 | -181 | 0 | -63.878 | -37.466 | -32.547 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |